227 related articles for article (PubMed ID: 32677888)
1. Optical microscopy reveals the dynamic nature of B. pseudomallei morphology during β-lactam antimicrobial susceptibility testing.
McLaughlin HP; Bugrysheva J; Sue D
BMC Microbiol; 2020 Jul; 20(1):209. PubMed ID: 32677888
[TBL] [Abstract][Full Text] [Related]
2. Rapid antimicrobial susceptibility testing and β-lactam-induced cell morphology changes of Gram-negative biological threat pathogens by optical screening.
McLaughlin HP; Sue D
BMC Microbiol; 2018 Dec; 18(1):218. PubMed ID: 30563467
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic Resistance Markers in Burkholderia pseudomallei Strain Bp1651 Identified by Genome Sequence Analysis.
Bugrysheva JV; Sue D; Gee JE; Elrod MG; Hoffmaster AR; Randall LB; Chirakul S; Tuanyok A; Schweizer HP; Weigel LM
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396541
[No Abstract] [Full Text] [Related]
4. In-vitro activity of β-lactams/trimethoprim-sulfamethoxazole combinations against different strains of Burkholderia pseudomallei.
Mohamad NI; Harun A; Hasan H; Deris ZZ
Trop Biomed; 2022 Mar; 39(1):11-16. PubMed ID: 35225295
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic susceptibility of clinical
Fen SHY; Tandhavanant S; Phunpang R; Ekchariyawat P; Saiprom N; Chewapreecha C; Seng R; Thiansukhon E; Morakot C; Sangsa N; Chayangsu S; Chuananont S; Tanwisaid K; Silakun W; Buasi N; Chaisuksant S; Hompleum T; Chetchotisakd P; Day NPJ; Chantratita W; Lertmemongkolchai G; West TE; Chantratita N
Antimicrob Agents Chemother; 2023 May; 95(5):. PubMed ID: 33593842
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of amoxicillin-clavulanate, doxycycline, ceftazidime, imipenem, and trimethoprim-sulfamethoxazole against biofilm of Brazilian strains of Burkholderia pseudomallei.
Bandeira Tde J; Moreira CA; Brilhante RS; Castelo-Branco Dde S; Neto MP; Cordeiro Rde A; Rodrigues Tde J; Rocha MF; Sidrim JJ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5771-3. PubMed ID: 24002089
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility and genetic characterisation of Burkholderia pseudomallei isolated from Malaysian patients.
Khosravi Y; Vellasamy KM; Mariappan V; Ng SL; Vadivelu J
ScientificWorldJournal; 2014; 2014():132971. PubMed ID: 25379514
[TBL] [Abstract][Full Text] [Related]
8. Assessing the colony morphotypes and antibiotic susceptibility profile of Malaysian clinical Burkholderia pseudomallei to support the use of EUCAST disk diffusion breakpoints to determine antibiotic resistance.
Hii SYF; Zaiful Bahrina NN; Mohd Zaidi MN; Hashim R; Ahmad N
Eur J Clin Microbiol Infect Dis; 2024 Feb; 43(2):373-378. PubMed ID: 37999783
[TBL] [Abstract][Full Text] [Related]
9. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis.
Castelo-Branco DS; Riello GB; Vasconcelos DC; Guedes GM; Serpa R; Bandeira TJ; Monteiro AJ; Cordeiro RA; Rocha MF; Sidrim JJ; Brilhante RS
J Appl Microbiol; 2016 Mar; 120(3):600-6. PubMed ID: 26669506
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of bla(PenA) and bla(OXA) in Burkholderia pseudomallei Isolated from Patients at Sappasitthiprasong Hospital and Their Susceptibility to Ceftazidime and Carbapenems.
Panya M; Thirat S; Wanram S; Panomket P; Nilsakul J
J Med Assoc Thai; 2016 Jan; 99 Suppl 1():S12-6. PubMed ID: 26817233
[TBL] [Abstract][Full Text] [Related]
11. Diffusion and activity of antibiotics against Burkholderia pseudomallei biofilms.
Pibalpakdee P; Wongratanacheewin S; Taweechaisupapong S; Niumsup PR
Int J Antimicrob Agents; 2012 Apr; 39(4):356-9. PubMed ID: 22364716
[TBL] [Abstract][Full Text] [Related]
12. In silico analyses of penicillin binding proteins in Burkholderia pseudomallei uncovers SNPs with utility for phylogeography, species differentiation, and sequence typing.
McLaughlin HP; Gulvik CA; Sue D
PLoS Negl Trop Dis; 2022 Apr; 16(4):e0009882. PubMed ID: 35417451
[TBL] [Abstract][Full Text] [Related]
13. Sesquiterpene farnesol contributes to increased susceptibility to β-lactams in strains of Burkholderia pseudomallei.
Brilhante RS; Valente LG; Rocha MF; Bandeira TJ; Cordeiro RA; Lima RA; Leite JJ; Ribeiro JF; Pereira JF; Castelo-Branco DS; Monteiro AJ; Sidrim JJ
Antimicrob Agents Chemother; 2012 Apr; 56(4):2198-200. PubMed ID: 22290941
[TBL] [Abstract][Full Text] [Related]
14. Impact of nutritional stress on drug susceptibility and biofilm structures of Burkholderia pseudomallei and Burkholderia thailandensis grown in static and microfluidic systems.
Anutrakunchai C; Bolscher JGM; Krom BP; Kanthawong S; Chareonsudjai S; Taweechaisupapong S
PLoS One; 2018; 13(3):e0194946. PubMed ID: 29579106
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of Clinical Isolates of
Sengyee S; Saiprom N; Paksanont S; Limmathurotsakul D; Wuthiekanun V; Chantratita N
Am J Trop Med Hyg; 2017 Jul; 97(1):62-67. PubMed ID: 28719324
[No Abstract] [Full Text] [Related]
16. Antimicrobial Susceptibility of Western Hemisphere Isolates of
Bugrysheva JV; Lascols C; McLaughlin HP; Gee JE; Elrod MG; Sue D
Microb Drug Resist; 2021 Sep; 27(9):1176-1185. PubMed ID: 33570476
[TBL] [Abstract][Full Text] [Related]
17. Study of
Zhang W; Guo Y; Yang Y; Dong D; Zheng Y; Zhu D; Hu F
Microb Drug Resist; 2020 Mar; 26(3):204-210. PubMed ID: 31553260
[No Abstract] [Full Text] [Related]
18. In-vitro activity of carbapenem antibiotics against beta-lactam susceptible and resistant strains of Burkholderia pseudomallei.
Smith MD; Wuthiekanun V; Walsh AL; White NJ
J Antimicrob Chemother; 1996 Mar; 37(3):611-5. PubMed ID: 9182118
[TBL] [Abstract][Full Text] [Related]
19. Tannic Acid-Stabilized Silver Nanoparticles Used in Biomedical Application as an Effective Antimelioidosis and Prolonged Efflux Pump Inhibitor against Melioidosis Causative Pathogen.
Srichaiyapol O; Thammawithan S; Siritongsuk P; Nasompag S; Daduang S; Klaynongsruang S; Kulchat S; Patramanon R
Molecules; 2021 Feb; 26(4):. PubMed ID: 33672903
[No Abstract] [Full Text] [Related]
20. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis.
Jenney AW; Lum G; Fisher DA; Currie BJ
Int J Antimicrob Agents; 2001 Feb; 17(2):109-13. PubMed ID: 11165114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
